Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer
Clinical trial NCT05039983 · COMPLETED
Trial details
- NCT number
- NCT05039983
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2023-12-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.